Skip to content

CapEx at other companies

Pfizer logo
PfizerPFE
$436M-22.7%
Eikon Therapeutics, Inc.
 logo
Eikon Therapeutics, Inc. EIKN
$262K-98.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0-100%
Replimune Group logo
Replimune GroupREPL
$135K-92.5%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$967K-27.3%
Erasca, Inc. logo
Erasca, Inc.ERAS
$36K-56.6%

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s capex?
OnKure Therapeutics, Inc. (OKUR) reported capex of $5K in Q1 2026.
How has OnKure Therapeutics, Inc.'s capex changed year-over-year?
OnKure Therapeutics, Inc.'s capex decreased by 72.2% year-over-year, from $18K to $5K.
What is the long-term trend for OnKure Therapeutics, Inc.'s capex?
Over 4 years (2021 to 2025), OnKure Therapeutics, Inc.'s capex has grown at a -30.6% compound annual growth rate (CAGR), from $198K to $46K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.